tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Eupraxia Pharmaceuticals Prices $70 Million Public Offering
PremiumCompany AnnouncementsEupraxia Pharmaceuticals Prices $70 Million Public Offering
7d ago
Eupraxia Pharmaceuticals 12.727M share Spot Secondary priced at $5.50
Premium
The Fly
Eupraxia Pharmaceuticals 12.727M share Spot Secondary priced at $5.50
7d ago
Closing Bell Movers: ACM Research up 5% after joining S&P SmallCap 600
Premium
The Fly
Closing Bell Movers: ACM Research up 5% after joining S&P SmallCap 600
7d ago
Eupraxia Pharmaceuticals Reports Promising 1-Year Results for EoE Treatment
PremiumCompany AnnouncementsEupraxia Pharmaceuticals Reports Promising 1-Year Results for EoE Treatment
28d ago
Eupraxia Pharmaceuticals announces data from RESOLVE trial in EoE
Premium
The Fly
Eupraxia Pharmaceuticals announces data from RESOLVE trial in EoE
28d ago
Celldex data supports positive Eupraxia thesis, says H.C. Wainwright
Premium
The Fly
Celldex data supports positive Eupraxia thesis, says H.C. Wainwright
1M ago
Eupraxia Pharmaceuticals to Present at Key Investor Conferences
PremiumCompany AnnouncementsEupraxia Pharmaceuticals to Present at Key Investor Conferences
2M ago
Promising Developments in Eupraxia Pharmaceuticals’ EoE Trial Justify Buy Rating
Premium
Ratings
Promising Developments in Eupraxia Pharmaceuticals’ EoE Trial Justify Buy Rating
3M ago
Eupraxia Pharmaceuticals Advances RESOLVE Trial with First Patient Dosed in Phase 2b
Premium
Company Announcements
Eupraxia Pharmaceuticals Advances RESOLVE Trial with First Patient Dosed in Phase 2b
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100